Suppr超能文献

肿瘤浸润淋巴结中富含程序性死亡受体 1+T 细胞和调节性 T 细胞,与甲状腺乳头状癌侵袭性特征相关。

Programmed death-1+ T cells and regulatory T cells are enriched in tumor-involved lymph nodes and associated with aggressive features in papillary thyroid cancer.

机构信息

University of Colorado, Anschutz Medical Campus, Aurora, Colorado 80045, USA.

出版信息

J Clin Endocrinol Metab. 2012 Jun;97(6):E934-43. doi: 10.1210/jc.2011-3428. Epub 2012 Mar 30.

Abstract

CONTEXT

Recurrent metastatic lymph node (LN) disease is common in patients with papillary thyroid cancer (PTC). Novel prognostic markers may be helpful in guiding a therapeutic approach. Our previous studies revealed that immune suppression is evident in PTC and associated with more severe disease.

OBJECTIVE

To characterize the immune response to metastatic PTC, we assessed CD4(+) T cell polarization in LN. In addition, we investigated the role of programmed death-1 (PD-1) and T cell exhaustion.

DESIGN

Uninvolved (UILN) and tumor-involved lymph nodes (TILN) were sampled ex vivo by fine-needle biopsy. T cell subsets were identified by flow cytometry. In parallel, archived TILN specimens were characterized by immunofluorescence.

SETTING

The study was conducted at the University of Colorado Hospital.

PATIENTS

Data were collected on 94 LN from 19 patients with PTC undergoing neck dissection.

MAIN OUTCOME

T cell subset frequencies were compared in UILN and TILN and assessed for correlation with recurrent disease and extranodal invasion.

RESULTS

Regulatory CD4(+) T cells (Treg) were enriched in TILN compared with UILN and further elevated in TILN from patients with recurrent disease. PD-1(+) T cells were present at high frequency in TILN and markedly enriched in TILN that showed evidence of extranodal invasion. In TILN, Treg frequency correlated with PD-1(+) T cell frequencies. Although PD-1(+) T cells produced interferon-γ, they failed to fully down-regulate CD27 and were not actively proliferating.

CONCLUSIONS

Increased Treg and PD-1(+) T cell frequencies in LN may be indicative of aggressive recurrent PTC. Future prospective studies are necessary to determine the prognostic and therapeutic value of these findings in PTC.

摘要

背景

甲状腺乳头状癌(PTC)患者常发生复发性转移性淋巴结(LN)疾病。新的预后标志物可能有助于指导治疗方法。我们之前的研究表明,PTC 存在免疫抑制,且与更严重的疾病相关。

目的

为了描述转移性 PTC 的免疫反应,我们评估了 LN 中 CD4+T 细胞的极化。此外,我们还研究了程序性死亡受体-1(PD-1)和 T 细胞耗竭的作用。

设计

通过细针穿刺活检对未受累(UILN)和肿瘤受累的淋巴结(TILN)进行体外采样。通过流式细胞术鉴定 T 细胞亚群。同时,通过免疫荧光法对存档的 TILN 标本进行了特征分析。

地点

该研究在科罗拉多大学医院进行。

患者

对 19 例接受颈部清扫术的 PTC 患者的 94 个 LN 进行了数据收集。

主要结果

比较 UILN 和 TILN 中的 T 细胞亚群频率,并评估其与复发性疾病和淋巴结外侵犯的相关性。

结果

与 UILN 相比,TILN 中调节性 CD4+T 细胞(Treg)增多,且在复发性疾病患者的 TILN 中进一步升高。PD-1+T 细胞在 TILN 中高频出现,并在显示淋巴结外侵犯证据的 TILN 中明显富集。在 TILN 中,Treg 频率与 PD-1+T 细胞频率相关。尽管 PD-1+T 细胞产生了干扰素-γ,但它们未能完全下调 CD27,也没有积极增殖。

结论

LN 中 Treg 和 PD-1+T 细胞频率的增加可能表明侵袭性复发性 PTC。需要进一步前瞻性研究来确定这些发现对 PTC 的预后和治疗价值。

相似文献

3
Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer.
J Clin Endocrinol Metab. 2010 May;95(5):2325-33. doi: 10.1210/jc.2009-2564. Epub 2010 Mar 5.
4
Papillary thyroid cancer: controversies in the management of neck metastasis.
Laryngoscope. 2008 Dec;118(12):2161-5. doi: 10.1097/MLG.0b013e31818550f6.
6
Central nodal metastases in papillary thyroid carcinoma based on tumor histologic type and focality.
Arch Otolaryngol Head Neck Surg. 2010 Jul;136(7):692-6. doi: 10.1001/archoto.2010.112.
8
Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Langenbecks Arch Surg. 2018 May;403(3):325-332. doi: 10.1007/s00423-018-1657-2. Epub 2018 Feb 14.
9
Elevated Cancer-Associated Hyaluronan Correlates With Diagnosis and Lymph Node Metastasis of Papillary Thyroid Cancer.
Lab Invest. 2024 Aug;104(8):102104. doi: 10.1016/j.labinv.2024.102104. Epub 2024 Jun 28.
10
Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
Head Neck. 2015 Sep;37(9):1336-43. doi: 10.1002/hed.23747. Epub 2014 Oct 29.

引用本文的文献

1
Research Progress on the Immunological Correlation Between Papillary Thyroid Carcinoma and Hashimoto's Thyroiditis.
J Immunol Res. 2025 Apr 23;2025:7192808. doi: 10.1155/jimr/7192808. eCollection 2025.
2
Therapeutic treatments targeting communication between angiogenic and immune microenvironments in thyroid cancers.
Curr Opin Endocr Metab Res. 2024 Dec;37. doi: 10.1016/j.coemr.2024.100544. Epub 2024 Aug 14.
3
BRAFV600E/pTERT double mutated papillary thyroid cancers exhibit immune gene suppression.
Front Endocrinol (Lausanne). 2024 Dec 9;15:1440722. doi: 10.3389/fendo.2024.1440722. eCollection 2024.
4
Th17/Treg cell balance in patients with papillary thyroid carcinoma: a new potential biomarker and therapeutic target.
Front Oncol. 2024 Oct 29;14:1325575. doi: 10.3389/fonc.2024.1325575. eCollection 2024.
7
Causal role of immune cells in thyroid cancer: a bidirectional Mendelian randomization study.
Front Immunol. 2024 Jun 17;15:1425873. doi: 10.3389/fimmu.2024.1425873. eCollection 2024.
8
Characterization of Immune Infiltrate Along the Leading Edge of Differentiated Thyroid Cancer.
Thyroid. 2024 Aug;34(8):999-1006. doi: 10.1089/thy.2024.0072. Epub 2024 Jul 12.
9
Predominance of CD4+ T cells in metastatic cervical lymph nodes in papillary thyroid carcinoma.
Endocr Connect. 2024 Jul 17;13(8). doi: 10.1530/EC-24-0135. Print 2024 Aug 1.
10
Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapy.
Front Immunol. 2024 May 29;15:1369780. doi: 10.3389/fimmu.2024.1369780. eCollection 2024.

本文引用的文献

1
Early T cell signalling is reversibly altered in PD-1+ T lymphocytes infiltrating human tumors.
PLoS One. 2011 Mar 7;6(3):e17621. doi: 10.1371/journal.pone.0017621.
6
Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer.
Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):7875-80. doi: 10.1073/pnas.1003345107. Epub 2010 Apr 12.
7
Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer.
J Clin Endocrinol Metab. 2010 May;95(5):2325-33. doi: 10.1210/jc.2009-2564. Epub 2010 Mar 5.
8
Features of responding T cells in cancer and chronic infection.
Curr Opin Immunol. 2010 Apr;22(2):223-30. doi: 10.1016/j.coi.2010.02.005. Epub 2010 Mar 6.
9
Protumor vs antitumor functions of IL-17.
J Immunol. 2009 Oct 1;183(7):4169-75. doi: 10.4049/jimmunol.0901017.
10
Human prostate-infiltrating CD8+ T lymphocytes are oligoclonal and PD-1+.
Prostate. 2009 Nov 1;69(15):1694-703. doi: 10.1002/pros.21020.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验